Clinical Trial

PD Catheter Survival: Modified Percutaneous vs Moncrief-Popovich

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Peritoneal dialysis (PD) catheter placement technique may affect catheter survival, functionality and infection risk. The Moncrief-Popovich (subcutaneous burying or embedding) technique was developed to reduce exit-site/tunnel infections during the interval between insertion and first use. Objective: Compare PD catheter survival, functionality and complication rates between conventional modified percutaneous placement and Moncrief-Popovich in adults initiating planned PD. Brief methods: Prospective, randomized, parallel-arm study enrolling adult CKD patients scheduled for planned PD initiation and catheter placement at Hospital Civil de Guadalajara between Jan 2024 and Dec 2025. Patients randomized 1:1 to conventional modified percutaneous placement group or Moncrief-Popovich buried catheter group. Primary outcome is catheter survival/functionality during follow-up. Secondary outcomes include infectious and mechanical complications, peritonitis incidence, and need to change dialysis modality.
Trial Details
NCT Number NCT07465445
Lead Sponsor Hospital Civil de Guadalajara
Conditions Chronic Kidney Disease (CKD) Stage 5, Peritoneal Dialysis Access
Enrollment 60 participants
Start Date 2024-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-12